Skip to main content
. 2012 Nov 8;93(6):429–437. doi: 10.1111/j.1365-2613.2012.00843.x

Figure 3.

Figure 3

Representative sections of control (a, c) and caffeine-treated (b, d) prostatic lobes submitted to immunohistochemistry for Ki-67. Ventral (a, b) and dorsal (c, d) prostates. Note an increased number of Ki-67 positive nuclei (arrows) in caffeine-treated ventral prostates when compared with control. Scale bars: 30 μm.